AZURRX BIOPHARMA, INC. SELLING AGENT AGREEMENTSelling Agent Agreement • May 14th, 2019 • AzurRx BioPharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 14th, 2019 Company Industry JurisdictionAzurRx Biopharma, Inc., a corporation organized and existing under the laws of State of Delaware (the “Company”), proposes to issue and sell to the purchasers identified on Schedule A (each a “Purchaser” and collectively, the “Purchasers”), pursuant to the terms and conditions of this Selling Agent Agreement (this “Agreement”), up to an aggregate of $2,883,842.00 in shares (the “Shares”) of common stock, par value $0.0001, of the Company (“Common Stock”). The Company hereby confirms its agreement with Alexander Capital L.P. (the “Selling Agent”) to act as Selling Agent in accordance with the terms and conditions hereof.
AZURRX BIOPHARMA, INC. SELLING AGENT AGREEMENTSelling Agent Agreement • April 3rd, 2019 • AzurRx BioPharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 3rd, 2019 Company Industry JurisdictionAzurRx Biopharma, Inc., a corporation organized and existing under the laws of State of Delaware (the “Company”), proposes to issue and sell to the purchasers identified on Schedule A (each a “Purchaser” and collectively, the “Purchasers”), pursuant to the terms and conditions of this Selling Agent Agreement (this “Agreement”), up to an aggregate of $2,758,200.90 in shares (the “Shares”) of common stock, par value $0.0001, of the Company (“Common Stock”). The Company hereby confirms its agreement with Alexander Capital L.P. (the “Selling Agent”) to act as Selling Agent in accordance with the terms and conditions hereof.
LONG ISLAND ICED TEA CORP. SELLING AGENT AGREEMENTSelling Agent Agreement • January 25th, 2017 • Long Island Iced Tea Corp. • Beverages • New York
Contract Type FiledJanuary 25th, 2017 Company Industry JurisdictionLong Island Iced Tea Corp., a corporation organized and existing under the laws of State of Delaware (the “Company”), proposes to issue and sell to the purchasers, pursuant to the terms and conditions of this Selling Agent Agreement (this “Agreement”) and the Subscription Agreements in the form of Exhibit A attached hereto (the “Subscription Agreements”) entered into with the purchasers identified therein (each a “Purchaser” and collectively, the “Purchasers”), up to an aggregate of $2,500,000 in shares of common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Securities”). The Company hereby confirms its agreement with Alexander Capital L.P. (the ”Selling Agent”) to act as Selling Agent in accordance with the terms and conditions hereof.